Skip to main content
. 2019 May 22;36(7):1606–1617. doi: 10.1007/s12325-019-00984-9

Table 1.

Demographics and preoperative characteristics (n = 44 eyes of 31 patients)

iStent inject (44 eyes)
Gender M/F 23/21

Age (years)

Mean ± SD (range)

71.3 ± 10.5

(40–88)

Race 100% Caucasian

 C:D ratio

 Mean ± SD (range)

0.8 ± 0.1

(0.5–1.0)

 VF MD (dB)

 Mean ± SD (range)

– 6.4 ± 6.9 dB

(− 24.4 to − 0.3)

Type of glaucoma n (%)

 POAG

 PXG

38 (86.4%)

4 (9.1%)

 Appositional narrow anglea 1 (2.3%)
 Secondary (neovascular) 1 (2.3%)
Mean medicated IOP (mmHg); mean ± SD 25.3 ± 6.0 mmHg
Medicated IOP level (mmHg) n (%)
 ≤ 15 mmHg 1 (2.3%)
 ≤ 18 mmHg 4 (9.1%)
Mean # medications; mean ± SD 2.98 ± 0.88
Eyes with prior glaucoma surgery n (%) 22 (50.0%)
Prior glaucoma surgeries, n = 35 surgeriesb
 Trabeculectomy 13
 CPC 14
 ALT/SLT 3
 Laser iridotomy 2
 Single iStent 1
 XEN implantation 2
Eyes on 3–5 preoperative medications, n (%) 33 (75%)

SD standard deviation, C:D cup to disc, VF MD visual field mean deviation, CPC cyclophotocoagulation, ALT argon laser trabeculoplasty, SLT selective laser trabeculoplasty

aEyes had open-angle configuration in the area of iStent inject implantation

bEyes could have more than one surgery (there were 35 surgeries in 22 eyes)